SG11202011365XA - Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells - Google Patents

Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells

Info

Publication number
SG11202011365XA
SG11202011365XA SG11202011365XA SG11202011365XA SG11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA SG 11202011365X A SG11202011365X A SG 11202011365XA
Authority
SG
Singapore
Prior art keywords
derived
stem cell
pluripotent stem
inducing differentiation
conjunctival cells
Prior art date
Application number
SG11202011365XA
Other languages
English (en)
Inventor
Kohji Nishida
Ryuhei Hayashi
Kimihito Nomi
Original Assignee
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka filed Critical Univ Osaka
Publication of SG11202011365XA publication Critical patent/SG11202011365XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202011365XA 2018-05-23 2019-05-22 Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells SG11202011365XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018098954 2018-05-23
PCT/JP2019/020364 WO2019225672A1 (ja) 2018-05-23 2019-05-22 多能性幹細胞由来結膜細胞の誘導方法

Publications (1)

Publication Number Publication Date
SG11202011365XA true SG11202011365XA (en) 2020-12-30

Family

ID=68616983

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202011365XA SG11202011365XA (en) 2018-05-23 2019-05-22 Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells

Country Status (8)

Country Link
US (1) US20210207087A1 (ko)
EP (1) EP3783097A4 (ko)
JP (1) JP7107595B2 (ko)
KR (1) KR20210015789A (ko)
CN (1) CN112189049B (ko)
AU (1) AU2019273567A1 (ko)
SG (1) SG11202011365XA (ko)
WO (1) WO2019225672A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023190745A1 (ja) * 2022-04-01 2023-10-05 国立大学法人大阪大学 結膜上皮マーカーおよびその利用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006129724A (ja) * 2004-11-02 2006-05-25 Senju Pharmaceut Co Ltd ラクリチン活性を有する化合物のスクリーニング方法
US20100184221A1 (en) * 2007-07-13 2010-07-22 Seiichi YOKOO Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell
WO2016114285A1 (ja) 2015-01-15 2016-07-21 国立大学法人大阪大学 多能性幹細胞からの角膜上皮細胞の分化誘導

Also Published As

Publication number Publication date
AU2019273567A1 (en) 2020-12-03
KR20210015789A (ko) 2021-02-10
JPWO2019225672A1 (ja) 2021-05-13
EP3783097A1 (en) 2021-02-24
EP3783097A4 (en) 2021-04-14
US20210207087A1 (en) 2021-07-08
CN112189049B (zh) 2023-12-15
JP7107595B2 (ja) 2022-07-27
WO2019225672A1 (ja) 2019-11-28
CN112189049A (zh) 2021-01-05

Similar Documents

Publication Publication Date Title
EP3491134A4 (en) PLURIPOTENT HUMAN INDUCED STEM CELLS FOR HIGH-PERFORMANCE GENETIC ENGINEERING
EP3246394A4 (en) Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells
IL250132A0 (en) A method to induce t-cell immunocytotherapy from stem cell potential
HK1212148A2 (en) A method for the isolation and cultivation of mesenchymal stem cells from umbilical cords, and a method for the differentiation of the umbilical cord-derived mesenchymal stem cells into various mesenchymal tissues
EP3150705A4 (en) Method for inducing myocardial differentiation of pluripotent stem cells using low-molecular compound
EP3540067A4 (en) METHOD OF INTRODUCING EXOGENOUS MITOCHONDRIA INTO CELLS
EP3453753A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS
IL277025A (en) Methods for improving the differentiation of stem cells into beta cells
EP3272858A4 (en) Method for producing naïve pluripotent stem cells
EP3750985A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN INTESTINAL EPITHELIAL CELLS
IL282637A (en) Methods for allogeneic transplantation of hematopoietic stem cells
SG11201706886PA (en) Cell culture method for mesenchymal stem cells
EP3702444A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN HEPATOCYTE
EP3196297A4 (en) Method for producing cardiomyocyte population from pluripotent stem cells
EP3202896A4 (en) Method for culturing pluripotent stem cells
EP3431584A4 (en) FREEZING METHOD FOR AGGREGATES OF MYOKARD CELLS DERIVED FROM PLURIPOTENTIAL STEM CELLS
IL281751A (en) Methods for inducing differentiation in mesenchymal stem cells
IL263557B (en) Differentiation of pluripotent stem cells into iris cells
IL285083A (en) Culture media for pluripotent stem cells
EP3587559A4 (en) MANUFACTURING METHOD FOR ARTIFICIAL PLURIPOTENT STEM CELLS
EP3578640A4 (en) DIFFERENTIATION CONTROL METHOD FOR PLURIPOTENT STEM CELLS
PL3436568T3 (pl) Podłoże hodowlane do pluripotencjalnych komórek macierzystych
IL294152A (en) A method for culturing hematopoietic stem cells
IL274746A (en) A method for cell culture
EP3421598A4 (en) METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS BY REDUCING THEIR INDIFFERENTIATED STATE